HCW Biologics Inc (HCWB)
0.7374
-0.26
(-26.26%)
USD |
NASDAQ |
Jun 21, 16:00
0.9709
+0.23
(+31.67%)
Pre-Market: 20:00
HCW Biologics Total Liabilities (Quarterly): 21.69M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 21.69M |
| December 31, 2023 | 15.05M |
| September 30, 2023 | 11.75M |
| June 30, 2023 | 10.90M |
| March 31, 2023 | 10.92M |
| December 31, 2022 | 9.381M |
| September 30, 2022 | 8.798M |
| Date | Value |
|---|---|
| June 30, 2022 | 1.243M |
| March 31, 2022 | 1.557M |
| December 31, 2021 | 2.322M |
| September 30, 2021 | 2.394M |
| June 30, 2021 | 4.169M |
| March 31, 2021 | 1.347M |
| December 31, 2020 | 1.001M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.001M
Minimum
Dec 2020
21.69M
Maximum
Mar 2024
7.322M
Average
6.484M
Median
Total Liabilities (Quarterly) Benchmarks
| CEL-SCI Corp | 15.74M |
| AIM ImmunoTech Inc | 11.36M |
| IGC Pharma Inc | 2.206M |
| NovaBay Pharmaceuticals Inc | 5.197M |
| Protalix BioTherapeutics Inc | 60.04M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 30.43M |
| Shareholders Equity (Quarterly) | 8.741M |
| Debt to Equity Ratio | 0.9606 |
| Current Ratio | 0.4629 |
| Net Debt Paydown Yield | -0.60% |